25 /100
LOW RISK
Score updated Apr 13, 2026

TBPH

Theravance Biopharma, Inc. — Stock Dilution Tracker

Track TBPH dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track TBPH — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
60
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
20%
🔁 Convertible Conversion 40%
• Significant convertible debt: 27% potential dilution
• Elevated convertible risk (60/100)
🔔 Track TBPH — Get forecast alerts →
💹 Market Data
Market Cap$841.91M
Shares Outstanding51.49M
Float24.13M
Cash$315.36M
Debt$42.70M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 1.5% shares (2025Q4 vs prior)
168 institutional holders · 50.50M shares
#1 Madison Avenue Partners, LP 9.51M shares
#2 Weiss Asset Management LP 7.46M shares
#3 Newtyn Management, LLC 4.30M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest5.26M
Days to Cover7.8
% of Float21.8%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL CONVERTIBLE Jun 30, 2022
Full SEC filing analysis available with free account
📰 Recent News
Track TBPH Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TBPH — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required